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Objectives The aim of our study was to assess coronary vasomotion after successful revascularization of chronic total
occlusion (CTO).
Background It is largely unknown whether the recovery of anterograde flow after CTO recanalization with drug-eluting stent
implantation affects vascular function in distal coronary segments.
Methods One hundred consecutive CTOs successfully treated with drug-eluting stents underwent coronary diameter mea-
surement after intracoronary nitroglycerin injection 5, 20, and 35 mm distal to the stented coronary segment
using 3-dimensional quantitative coronary angiography. In a subgroup of 14 patients, coronary vasomotion was
tested in distal segments: incremental atrial pacing for endothelium-dependent cases; and intracoronary nitro-
glycerin injection for endothelium-independent cases. In another subgroup of 13 patients, distal vessels were
assessed by intracoronary ultrasounds.
Results Vessel diameters significantly increased at follow-up as compared to baseline values (2.0  0.52 mm vs.
2.25  0.50 mm, 1.76  0.49 mm vs. 2.05  0.58 mm, 1.54  0.53 mm vs. 2.04  0.58 mm, at each seg-
ment analyzed; p  0.001). At baseline, distal segments failed to respond to both endothelium-dependent and
-independent stimuli. At follow-up, atrial pacing induced vasoconstriction, whereas nitroglycerine administration
resulted in significant vasodilation (p  0.05). Intracoronary ultrasounds failed to show changes of the cross-
sectional area of distal segments at follow-up angiography.
Conclusions Recanalization of CTO is followed by a hibernation of vascular wall at distal coronary segments that fail to re-
spond to endothelium-dependent and -independent stimuli. Distal vessel diameter increases over time in the
absence of positive remodeling and in spite of persistent endothelial dysfunction. This severe impairment of
vasomotor tone after CTO reopening suggests that intracoronary ultrasound assessment is of paramount impor-
tance for the selection of stent size. (J Am Coll Cardiol 2012;59:711–8) © 2012 by the American College of
Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.10.894Chronic total occlusion (CTO) pathophysiology is not fully
elucidated yet; some studies suggest that occlusion is prob-
ably caused by thrombus and lipid-rich cholesterol esters
that are replaced over time by collagen and calcium depo-
sition (1). Experimental models showed endothelial cell
necrosis in response to vessel ligation (2), whereas more
recent models suggest that the endothelium might retain
viability guiding the subsequent development of CTO,
including CTO neo-revascularization, which occurs within
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2011, accepted October 17, 2011.the lumen and in various layers of the vessel wall, by the
release of paracrine substances (3,4).
It is uncertain whether after CTO recanalization the
recovery of anterograde reverses endothelial dysfunction,
thus promoting vasodilation and positive remodeling.
The aim of the present clinical study was to investigate
the distal coronary vessel after successful percutaneous
coronary intervention (PCI) of CTO using drug-eluting
stents, assessing both vasomotion and remodeling.
Methods
Study population. All patients undergoing PCI of CTO at
our hospital between October 2005 and October 2008 were
screened for enrollment in this prospective study. Patients
were eligible for inclusion if procedural success was
achieved, defined as angiographic success (final residual
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2) in the absence of procedural
cardiac adverse events and reste-
nosis at follow-up. Exclusion cri-
teria were: life expectancy (2
years), low left ventricular ejec-
tion fraction (40%), significant
lesions in left main coronary ar-
tery (30% of luminal diameter).
Angiographic follow-up was
scheduled at 9 to 12 months for
all patients who consented to
participate in the study. Patients
who underwent repeat angiogra-
phy in the absence of restenosis
and/or of adverse events during
follow-up represented the final
study population.
The study was performed ac-
cording to the Declaration of
Helsinki and World Health Or-
ganization guidelines. The study
was carried out at the Clinical Division of Cardiology of
Ferrarotto Hospital, University of Catania. The ethics
committee approved the entire protocol including pacing
and intravascular ultrasound substudies, and all patients
gave written informed consent for coronary angiography
and the endothelial function test.
Interventional procedures. All patients received intrave-
nous hydration with 1 ml/kg/h of saline the day before and
after PCI. At the beginning of the procedure, patients
received intravenous unfractionated heparin (100 IU/kg) to
maintain activated clotting time higher than 300 s, activated
clotting time was measured every 30 min and, if required,
additional boluses of unfractionated heparin were adminis-
tered during the procedures. No glycoprotein IIb/IIIa in-
hibitors were administered. Expert operators performed the
procedures. CTO revascularization strategies were left to
the operators’ discretion. All procedures were performed via
the femoral route, using double coronary cannulation. Sev-
eral guidewire strategies were used including single-wire
technique, parallel-wire technique, intravascular ultra-
sound–guided wiring technique, and retrograde wiring
through collaterals with its refinements (such as pure retro-
grade wiring, kissing wiring, knuckle, CART [controlled
antegrade retrograde tracking], and reverse CART tech-
niques), as previously described (5). In several cases, the
Crosser system (Bard Peripheral Vascular Inc., Tempe,
Arizona) was used as previously shown (6). Drug-eluting
stents only were implanted. Notably, no vasoactive drugs,
including nitroglycerine and adenosine, were administered
during the procedures. As a final procedural stage, in all
patients, at least 2 orthogonal coronary angiograms were
obtained after intracoronary (IC) administration of nitro-
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ANCOVA  analysis of
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occlusion









RVD  reference vessel
diameter
SMC  smooth muscle cell
TIMI  Thrombolysis In
Myocardial Infarctionglycerine (200 g total dose); the same projections were sthen used at follow-up after IC administration of the same
dose of nitrates.
Coronary vasomotor study protocol. To assess endo-
thelium-dependent coronary vasomotion, a pacing study
was performed in a subgroup of patients. In these patients,
all vasoactive drugs were discontinued at least 24 h before
catheterization except for sublingual nitroglycerin, which
was allowed up to 1 h before the index or repeat angiogra-
phy. Long-acting beta-blockers were stopped 48 h before
the study. Before IC nitrate administration, a 5-F bipolar
pacing wire (St. Jude Medical, St. Paul, Minnesota) was
placed against the high lateral right atrial wall, using the
femoral vein route, at the end of both index and repeat
angiographies. After control conditions were established,
rapid atrial pacing was conducted with steps of 20 beats/min
increase above baseline heart rate for 2 min, until reaching
the final pacing rate of 150 beats/min. The pacing protocol
was interrupted in cases of angina or when atrioventricular
Wenckebach block occurred. In this latter case, atrioven-
tricular Wenckebach block was not treated with intravenous
atropine so as not to influence coronary vasomotion and
blood flow responses. Angiograms were obtained at baseline
and at the end of a 2-min period at each pacing rate, within
beats after ending the highest pacing step. Finally, the
endothelium-independent vasomotor response was evalu-
ated with administration of IC nitroglycerine bolus 200 g,
mmediately before coronary angiography.
uantitative coronary angiography. Analysis of quantita-
ive coronary angiography (QCA) was performed by the
nstitutional core laboratory (Ferrarotto Hospital, University
f Catania, Catania, Italy) using the CardiOp-B system
Paeion Medical Ltd., Rosh Hayin, Israel). The system
ncludes a software package that runs on off-the-shelf
ardware and performs a 3-dimensional reconstruction of
he obstructed vessel as well as provides quantitative cross-
ection information combining two 2-dimensional angio-
raphic projections (7). One experienced technician blinded
o the patients’ identities and outcomes, performed offline
uantitative analysis of angiographic data using end-
iastolic images selected from each of the different projec-
ions. After calibration using a catheter-based scaling factor,
he operator marked the proximal and distal reference points
n addition to a third point, which is used as an anchor
etween different images. At this stage, the software is able
o create a 3-dimensional reconstruction of coronary vessel.
sing the software’s tool, traditional QCA parameters,
ncluding reference vessel diameter (RVD), minimal lumen
iameter, and diameter stenosis, were obtained, at 5, 20, and
5 mm distal to the distal stent edge (8,9). The intraob-
erver variability of our technician for RVD measurement is
.94.
ssessment of coronary remodeling. In another subgroup
f patients intracoronary ultrasound (ICUS) was also per-
ormed at the end of both index and repeat angiography.
atients with at least a 35-mm distal coronary segment
uitable for ICUS examination were included in this suba-
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g of nitroglycerin, using the Galaxy system (Boston
Scientific, Fremont, California), using a 40-MHz, 2.6-F
rapid exchange probe (Atlantis-Pro, Boston Scientific).
Image acquisition using automated transducer pullback at
0.5 mm/s was performed from at least 35 mm distal to the
distal stent edge retrograde to the aorto-ostial junction.
Offline analysis was performed with a commercially avail-
able program for computerized planimetry (EchoPlaque,
INDEC System, Mountain View, California). ICUS im-
ages were analyzed by side-by-side viewing in post-
procedure and follow-up studies. Review of landmarks and
pullback speed, frame-by-frame comparison for matching
segments, and digitization of images were carried out by 2
expert operators of our core laboratory. The intraclass
coefficients for interobserver variability of measurement of
plaque and vessel volumes in our laboratory are 0.98 and
0.99, respectively. Interpolation of the lumen and external
elastic membrane contours was performed according to an
acoustic quantification method and a nonlinear algorithm,
respectively, as previously described (10). At every 5-mm
axial length segment from the distal stent edge, lumen
diameter, external elastic membrane (EEM) diameter, and
lumen and EEM cross-sectional areas were measured. The
EEM was measured at the leading edge of the adventitia. A
total of 107 cross sections were analyzed in the segment of
interest at post-procedure and follow-up evaluations. Com-
parisons were made between the post-intervention and
follow-up data.
Statistical analysis. The sample size was calculated con-
sidering the results of QCA analysis; therefore, assuming a
0.45-mm standard deviation of RVD, a total sample size of
87 analyzed lesions was estimated to detect a difference of
0.2 mm between index and repeat angiography RVDs at
each coronary segment analyzed, with 95% of statistical
power and a beta error equal to 0.36. Taking into the
account a dropout rate of 40%, the sample size was set at
135 lesions. The dropout rate was predicted based on the
expected incidence of restenosis and failed QCA assess-
ment. For the vasomotor tone assessment, it was estimated
that a sample size of 13 patients was needed to detect with
95% of statistical power and assuming a difference of 0.35
mm in coronary RVD between the maximal pacing and IC
nitroglycerine administration at each segment studied. Con-
tinuous variables were analyzed for a normal distribution with
the Kolmogorov-Smirnov test and presented as mean SD or
as median and interquartile range if a normal distribution
was present or not, respectively. Student t test or Mann-
Whitney U test were used for comparison of continuous
variables as appropriate. Categorical variables are expressed
as frequencies and percentages. Categorical variables were
tested by means of the chi-square test or Fisher exact test
when at least 25% of values showed an expected cell
frequency below 5. A 2-tailed p value0.05 was considered
to indicate a statistically significant difference for all theanalyses performed. No corrections were made in cases of
multiple CTO lesions in the same patients.
A repeated measure analysis of covariance (ANCOVA)
model was used to compare the changes of RVD at each
coronary segment analyzed (5 mm, 20 mm, and 35 mm) at
index and repeat angiography, using as covariates diabetes,
stent type, and the diameter of the distal stent implanted.
One-way analysis of variance was used to test the differences
in diameter variation between the analyzed segments.
Spearman correlation test was used to show the relationship
between the baseline vessel diameter (measured at distal
stent edge) and the percentage of diameter variation. An-
other ANCOVA model was use to compare index proce-
dure ICUS results (measured at each 5 mm, from the distal
stent edge until 35 mm) with those obtained at follow-up.
Statistical analysis was performed using a SPSS software
(version 16.0, SPSS Inc., Chicago, Illinois).
Results
During the study period, 210 patients with 234 CTO
lesions were screened; among these, 87 patients with 100
CTO lesions constituted the final study population. Study
population and study protocol flow charts are shown in
Figures 1 and 2, respectively. Baseline clinical characteristics
of patients are reported in Table 1 and lesion angiographic
characteristics are in Table 2. The average of contrast load
administration per patient was 387 223 cc.
Figure 1 Study Population Flow Chart
The final sample of the study is represented by 100 chronic total occlusions
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raphy was performed in all patients after 11.7 2.8 months.
Comparing post-procedure and follow-up angiograms, a
significant increase of RVD was observed at each analyzed
coronary segment (2.0  0.52 mm vs. 2.25  0.50 mm,
1.76  0.49 mm vs. 2.05  0.58 mm, 1.54  0.53 mm vs.
2.04  0.58 mm, respectively, at 5, 20, and 35 mm distal to
stent edge; all p  0.001). A higher RVD at follow-up was
confirmed by ANCOVA analysis (p  0.001) (Fig. 3).
Diabetes, stent type, and distal stent diameter were included
in the ANCOVA model as covariates, but only distal stent
diameter was related to RVD changes (p  0.02). No
differences were observed by stratifying percentage RVD
variations according to diabetes status and type of implanted
stent (Fig. 4). A significant negative linear correlation was
found between vessel diameter measured at the distal stent
edge and percentage RVD change at follow-up (r  –0.5,
p  0.001) (Fig. 5).
Assessment of endothelium-dependent and -independent
vasomotion. Assessment of vasomotor tone was carried out
in 15 patients, but 1 patient was excluded for the occurrence
of restenosis at angiographic follow-up, thus 14 patients, 4
with type 2 diabetes, underwent assessment of endothelium
function. Sirolimus-eluting stents were implanted in 8
patients and paclitaxel-eluting stents in the remaining 6
Figure 2 Study Protocol Flow Chart
Angiograms were obtained at the end of chronic total occlusion percutaneous coro
rate. After that, the endothelium-independent vasomotor response was evaluated
before coronary angiography. Finally, intravascular ultrasound (IVUS) assessment w
Patients Characteristics (N  87)Table 1 Patients Characteristics (N  87)






Family history of coronary artery disease 45 (51.7)
Statins 78 (89.6)
ACE inhibitors 69 (79.3)
Beta-blockers 61 (70.1)
Nitrates 49 (56.3)
Calcium antagonist 22 (25.3)Values are mean  SD or n (%).
ACE  angiotensin-converting enzyme.patients. Table 3 reports mean vessel diameter assessed at
baseline, at peak pacing, and after IC administration of
nitroglycerine at both index and repeat angiography. At
index angiography, neither pacing nor nitroglycerine mod-
ified vessel diameters (Fig. 6A). In contrast, at follow-up,
atrial pacing resulted in significant vasoconstriction (Fig. 6B).
Vasoconstriction observed during pacing was similar in the
presence or absence of diabetes (–7.2  16.2% vs. –9.3 
6.4%, respectively; p  0.7) and with different stent types
(–10.4  11.1% vs. –6.4  7.1%, p 0.5 for sirolimus- and
paclitaxel-eluting stents, respectively). Of note, vasocon-
striction was greater in proximal than in distal segments
(–14.1  10.4%, 10.7  11.4%, and –8.7  9.5% at 5 mm,
0 mm, and 35 mm, respectively; p  0.001).
Intracoronary nitroglycerine administration resulted in
ignificant vasodilation in all 3 segments (Fig. 6B).
ssessment of coronary remodeling. Post-procedural and
ollow-up ICUS was performed in 13 patients; 2 patients
ere excluded for stent restenosis at follow-up. No differ-
nces were found in the EEM cross-sectional areas between
ndex and repeat angiography for segments assessed from 5
o 35 mm distal to the stent (3.62  0.94 mm2 vs. 3.70 
.85 mm2, 6.74  3.30 mm2 vs. 6.70  2.38 mm2, 6.04 
Lesions and Procedural CharacteristicsTable 2 Lesions and Procedural Characteristics
CTO culprit artery
Left anterior descending 31 (31)
Right coronary artery 49 (49)
Left circumflex artery 20 (20)
CTO duration, months 37.2 47.9
Lesion length 40 mm 37 (37)
Moderate/severe calcification 29 (29)
Tortuosity of occluded segment 33 (33)
Blunt stump 53 (53)
Number of stents implanted 2.8 1.4
Length of implanted stent, mm 61.3 27
SES use 51 (51)
PES use 37 (37)
ZES use 12 (12)
Values are n (%) or mean  SD. Lesions, n  100.
ntervention procedure (baseline) and at the end of a 2-min period at each pacing
ministration of an intracoronary (IC) nitroglycerine bolus of 200 g, immediately
rformed. The same protocol was executed at angiographic follow-up.nary i
with ad
as peCTO chronic total occlusion; PES paclitaxel-eluting stent(s); SES sirolimus-eluting stent(s);
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.2 mm2, 7.37  3.61 mm2 vs. 6.78  1.12 mm2, 8.75 
.75 mm2 vs. 9.17  3.15mm2, and 7.40  3.92 mm2 vs.
7.05  4.10 mm2, respectively; all p  NS). ANCOVA
odel confirmed lack of differences (Fig. 7). No significant
ifferences were also observed in lumen diameter, EEM
iameter, and intimal hyperplasia (Table 3).
iscussion
o the best of our knowledge, this is the first study to
nvestigate systematically coronary vessels distal to CTO
fter successful recanalization (11). Coronary CTO repre-
ents a unique in vivo pathophysiological model, in which
lterations of segments distal to the occlusion are mainly
etermined by severe shear stress reduction. Indeed, in the
istal coronary segments, the reduction of shear stress
esults in lesser endothelial release of vasodilators, in par-
icular of nitric oxide (12) and greater release of vasocon-
trictors, in particular endhotelin-1, thus favoring vasocon-
triction (13). Moreover, the endothelium promotes the
roliferation of “noncontractile” smooth muscle cells
SMCs) into the intima and structural alteration of extra-
ellular matrix. Vasoconstriction and entrenchment through
issue reorganization have been identified as the 2 consec-
tive phases of inward arterial remodeling (14). Of note,
nward (or constrictive) remodeling and plaque mass repre-
ent the most important factors determining the severity of
oronary luminal stenosis (15). In this study, immediately
fter successful CTO recanalization, coronary segments
istal to the implanted stent failed to respond to both
itrates (a nonendothelium-dependent stimulus) and atrial
acing (an endothelium-dependent stimulus). At follow-up,
istal segments dilated in response to nitrates; accordingly,
istal vessel diameter, assessed after nitrates, was consider-
bly greater at follow-up than immediately after drug-
luting stent implantation. The increase of distal vessel
Figure 3 Comparison of RVDs
Comparison of reference vessel diameters (RVDs) at each coronary segment
assessed between index procedure (black line) and at 9- to 12-month angio-
graphic follow-up (FU) (gray line). ANCOVA  analysis of covariance.iameter was not associated with outward remodeling asssessed by ICUS. Notably, atrial pacing at follow-up was
ssociated with vasoconstriction, thus suggesting persistent
ndothelium-dependent dysfunction.
The improvement of distal vessel diameter size detected at
ollow-up after CTO recanalization can theoretically be ex-
lained by 3 different mechanisms: 1) impaired endothelium-
ependent and/or -independent vasomotion immediately after
TO recanalization (hibernated vascular wall) and/or an in-
ense vasoconstriction that improves at follow-up; 2) positive
emodeling; or 3) a combination of both.
Coronary vasomotion at the site of atherosclerotic
laques and in coronary microcirculation reflects an elusive
ut important link between coronary atherosclerosis and the
linical manifestations of myocardial ischemia (16,17). In
ur study, the lack of response to atrial pacing suggests
mpairment of endothelium-dependent regulatory mecha-
isms. The endothelium plays a key role in the control of
asomotor tone through the nitric oxide–dependent and
independent mechanisms. The latter include complex
Figure 4 Percentage of Vessel Diameter Changes
Percentage of vessel diameter changes at 9- to 12-month angiographic
follow-up according to diabetes status (A) and drug-eluting stent type (B).
PES  paclitaxel-eluting stent(s); SES  sirolimus-eluting stent(s);
ZES  zotarolimus-eluting stent(s).
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Impaired Vasomotion After CTO Revascularization February 21, 2012:711–8pathways involving diffusible factors and/or the spread of
hyperpolarization through myoendothelial gap junction
(18). Furthermore, suppression of nitric oxide endothelial
production activates tissue transglutaminase, which might
induce changes in SMCs, including the assembly of actin
filaments, thus controlling SMCs orientation and elonga-
tion. As result, these ultrastructural changes might favor the
activation of SMCs with a subsequent increase in vasocon-
striction (19). Our study’s observation that immediately
after recanalization distal segments failed to respond to
nitrates suggests that a primary alteration of SMCs also is
likely to play an important role in this setting. The causes of
this primary impairment cannot be deduced by the results of
our study. Enhanced Rho-kinase activation leading to SMC
contraction might play an important pathogenetic role as
shown by Shimokawa and Takeshita (20) in experimental
models of coronary spasm as well as in humans. It is worth
noting that at follow-up angiography, distal vessels re-
Figure 5 Linear Correlation Between Baseline Vessel
Diameter and Percentage of Diameter Variation
Scatter dot plot reporting the negative linear correlation between baseline ves-
sel diameter and percentage of diameter variation at follow-up. RVD  refer-
ence vessel diameter.
IVUS Parameters Measured at Each SegmentTable 3 IVUS Parameters Measured at Each Segment
5 mm 10 mm 1
After procedure
Luminal diameter, mm 2.9 1.0 2.5 0.7 2.5
EEM diameter, mm 3.3 0.8 3.0 0.7 2.9
EEM area, mm2 8.5 1.4 6.8 3.3 6.1
Intimal hyperplasia, mm2 1.6 0.7 1.4 0.5 0.8
Angiographic follow-up
Luminal diameter, mm 2.5 0.2 2.4 0.5 2.4
EEM diameter, mm 3.1 0.3 2.9 0.6 2.9
EEM area, mm2 7.6 0.8 6.7 2.4 7.7
Intimal hyperplasia, mm2 2.8 1.7 2.1 1.5 2.1Values are mean  SD. All differences are not significant.
EEM external elastic membrane.sponded to nitrates, thus suggesting recovery of SMC
function, whereas they showed vasoconstriction in response
to atrial pacing, suggesting persistent endothelial dysfunc-
tion. Thus, it would appear that the time course of endo-
thelial and SMC function recovery is different. Persistent
endothelial dysfunction might well reflect the persistence of
risk factors, whereas the early, reversible alteration of SMC
Figure 6 Results of Endothelium Vasomotion Assessment
Mean diameter values at baseline, maximal pacing rate, and after intracoro-
nary nitroglycerine administration at each coronary segment assessed, at the
time of index procedure (A) and at 9- to 12-month angiographic follow-up (B).
All the significant p values are reported in Table 3. ANOVA  analysis of
variance.
20 mm 25 mm 30 mm 35 mm
2.3 0.8 2.5 0.7 2.4 0.9 2.2 0.7
2.8 0.9 3.0 0.7 3.0 0.7 2.7 0.9
6.6 4.2 7.4 3.6 8.7 3.7 7.4 3.9
1.4 1.1 1.4 0.5 1.5 1.2 1.3 0.6
2.4 0.6 2.7 0.3 3.0 0.8 2.7 0.9
2.8 0.7 3.2 0.1 3.5 0.5 3.2 0.6
7.7 3.2 7.8 1.1 9.2 3.1 7.1 4.1
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reduction of shear stress associated with CTO. It is inter-
esting to note that administration of iodinated contrast
media have complex vasomotor effects especially in CTO
PCI procedures where large amounts of contrast are used
(21). Similarly, aggressive guidewire manipulation can de-
termine an intense coronary vasoconstriction, which could
be a reasonable factor of vessel diameter changes seen at late
follow-up.
Notably, diabetes and stent type did not influence vessel
diameter changes observed at follow-up. Conversely, the
distal stent diameter, and thus the coronary segment distal
to it, yielded a significant effect on diameter improvement.
This finding might be related to the well-known association
between shear stress and vessel diameter (18). Accordingly,
a larger vessel diameter in the distal stented segment might
increase shear stress, thus facilitating the recovery of endo-
thelial vasodilator function at follow-up. The observation of
diverging patterns of vessel diameters in proximal and distal
coronary segments in response to nitrates could be explained
by the enhanced reactivity of distal epicardial vessels to
vasodilators, as shown previously by a study executed in
patients with stable angina and obstructive coronary athero-
sclerosis (22). This phenomenon could be the reason for the
observed inverse correlation between baseline RVD and the
percentage of vessel diameter changes.
In our study, ICUS shows that positive remodeling does
not account for the increase of distal vessel diameter
observed at follow-up angiography. Remodeling is a process
that determines a change of cross-sectional vessel area in
response to atherosclerosis (23). Although the initial re-
sponse to the formation of an atherosclerotic plaque is an
outward positive remodeling, further progression of the
atherosclerotic plaque can lead to inward remodeling usually
Figure 7 EEM CSAs
Comparison of elastic external membrane (EEM) cross-sectional area (CSA) at
each coronary segment assessed between index procedures (black line)
and at 9- to 12-month angiographic follow up (gray line). ANCOVA  analysis
of covariance.associated with stable plaques, lack of remodeling, or furtherpositive remodeling possibly associated with unstable
plaques (24,25). The reasons for these different evolutions
are still largely unknown, although it is widely accepted that
endothelial cells able to sense changes in shear stress play a
critical role. In our study, we did not measure shear stress. It
is likely, however, that recanalization of a CTO resulted in
a considerable increase in shear stress. Thus, the lack of
positive remodeling in our study seems to cast some shadow
on the notion that shear stress is a key factor in determining
remodeling. It might well be that shear stress is more
important in determining remodeling in the presence of
atherosclerotic plaques than in segments distal to CTO,
which did not necessarily exhibit a large atherosclerotic
burden.
Study limitations. This study presents some limitations
including the small number of patients, in particular in the
substudies on the assessment of endothelial dysfunction and
of arterial remodeling. The complexity of CTO recanaliza-
tion makes it difficult to prolong the procedure with
additional pathophysiological studies. Thus, a bias in our
study might have been the selection of patients undergoing
a faster CTO revascularization. Furthermore, the small
number of patients precluded the possibility to carry out an
extensive multivariate analysis of the predictors of endothe-
lial dysfunction, SMC dysfunction, and remodeling. The
absence of a reasonable standardized timing for the admin-
istration of nitroglycerine at the end of the procedure
represents another study limitation. Finally, the lack of an
appropriate control group of patients treated with long
segment stents for not chronically occluded vessels does not
permit us to clarify if distal diameter changes are or are not
unique to CTO lesions.
Conclusions
Recanalization of CTO is followed by a reversible hiberna-
tion of vascular wall at distal coronary segments that are
resistant to conventional doses of intracoronary nitrates.
The vascular wall dysfunction improves over time, resulting
in a larger lumen at follow-up; the improvement appears to
be related to recovery of SMC function rather than to
improvement of endothelial function or to positive remod-
eling. The clinical implications of our study are obvious.
Indeed, our results indicate that, the size of distal coronary
vessel immediately after CTO recanalization might lead to
an underestimation of stent size even after intracoronary
administration of conventional doses of nitrate. This severe
impairment of vasomotor tone after CTO reopening sug-
gests ICUS assessment for the selection of the correct stent
size and if the landing zone is of paramount importance, not
withstanding that aggressive post-dilation might increase
procedural complications in the complex PCI. Our study
also shed some light on the complex mechanisms responsi-
ble for vasomotion alterations and remodeling suggesting
that in this setting: 1) endothelial and smooth muscle
dysfunction have different time courses and, therefore,
718 Galassi et al. JACC Vol. 59, No. 8, 2012
Impaired Vasomotion After CTO Revascularization February 21, 2012:711–8probably different mechanisms; and 2) changes in shear
stress are not the only determinants of remodeling.
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